MetroBoston Clinical Partners — Boston, Massachusetts

MetroBoston Clinical Partners is a clinical research site located in Boston, Massachusetts, United States 02135.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

MetroBoston Clinical Partners has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Erythropoietic Protoporphyria, Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP).

Sponsors: Disc Medicine, Inc.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MetroBoston Clinical Partners?

MetroBoston Clinical Partners has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MetroBoston Clinical Partners conducted?

MetroBoston Clinical Partners has 2 clinical trials on record, with 2 currently active. Their work covers Erythropoietic Protoporphyria, Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP).

Is MetroBoston Clinical Partners accredited by Crixeo Health?

MetroBoston Clinical Partners has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MetroBoston Clinical Partners?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.